Bolt Biotherapeutics, Inc. (BOLT)
4.43
-0.19
(-4.11%)
USD |
NASDAQ |
Jun 10, 16:00
4.50
+0.07
(+1.58%)
After-Hours: 20:00
Bolt Biotherapeutics Total Liabilities (Quarterly) : 28.20M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 28.20M |
| December 31, 2025 | 35.90M |
| September 30, 2025 | 32.95M |
| June 30, 2025 | 36.66M |
| March 31, 2025 | 39.05M |
| December 31, 2024 | 42.43M |
| September 30, 2024 | 37.30M |
| June 30, 2024 | 38.32M |
| March 31, 2024 | 38.73M |
| December 31, 2023 | 47.04M |
| September 30, 2023 | 47.10M |
| June 30, 2023 | 48.56M |
| March 31, 2023 | 48.50M |
| Date | Value |
|---|---|
| December 31, 2022 | 56.30M |
| September 30, 2022 | 57.06M |
| June 30, 2022 | 52.27M |
| March 31, 2022 | 54.40M |
| December 31, 2021 | 57.60M |
| September 30, 2021 | 58.64M |
| June 30, 2021 | 51.18M |
| March 31, 2021 | 21.39M |
| December 31, 2020 | 46.19M |
| September 30, 2020 | 136.32M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 16.79M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sangamo Therapeutics, Inc. | 78.92M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Oncolytics Biotech, Inc. | 13.29M |
| Sarepta Therapeutics, Inc. | 1.674B |
| Anixa Biosciences, Inc. | 1.387M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.03M |
| Shareholders Equity (Quarterly) | 19.82M |
| Debt to Equity Ratio | 1.125 |
| Current Ratio | 3.507 |
| Net Debt Paydown Yield | 7.48% |